Uses, Dosage & Side Effects: Symtuza Tablet
Symtuza Tablet
| Generic name | Darunavir, cobicistat, emtricitabine, and tenofovir alafenamide |
|---|---|
| Drug class | Antiviral combination (HIV protease inhibitor, CYP3A inhibitor/booster, and two nucleoside/nucleotide reverse transcriptase inhibitors) |
| Forms | Film-coated tablet |
Symtuza is a single tablet containing four medicines that work together to treat HIV-1 infection. It is used in adults and children aged 12 and older (US) or 6 and older (EU) who weigh at least 40 kg (or 25 kg for the lower-strength EU tablet). It is not a cure for HIV, but it helps control the virus.
Read the full guideUses, dosage, side effects, precautions, and sources, written from the same verified facts.
General information, not medical advice
Your prescriber and the leaflet in your pack know your situation. This page does not.
- Follow your prescriber and the leaflet
- Don't start, stop, or change a dose on your own
- Doses and warnings differ by country and product
Took too much, or feel seriously unwell? Get urgent medical help now.
Facts checked by a personFull disclaimer
